HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pristanic acid does not accumulate in peroxisomal acyl-CoA oxidase deficiency: evidence for a distinct peroxisomal pristanyl-CoA oxidase.

Abstract
The concentration of pristanic acid was measured in plasma from a patient with an isolated peroxisomal very long chain fatty acid (VLCFA) acyl-CoA oxidase deficiency, a defect in peroxisomal beta-oxidation resulting in accumulation of VLCFA in plasma and tissues. Although peroxisomes are believed to be involved in pristanic acid beta-oxidation, the pristanic acid level in the patient's plasma was within the control range. This finding provides evidence for the existence of a pristanyl-CoA oxidase distinct from the specific trihydroxycholestanoyl-CoA and VLCFA acyl-CoA oxidases.
AuthorsH J ten Brink, B T Poll-The, J M Saudubray, R J Wanders, C Jakobs
JournalJournal of inherited metabolic disease (J Inherit Metab Dis) Vol. 14 Issue 5 Pg. 681-4 ( 1991) ISSN: 0141-8955 [Print] United States
PMID1779614 (Publication Type: Journal Article)
Chemical References
  • Fatty Acids
  • Phytanic Acid
  • pristanic acid
  • Oxidoreductases
  • pristanoyl-CoA oxidase
  • Acyl-CoA Oxidase
Topics
  • Acyl-CoA Oxidase
  • Fatty Acids (metabolism)
  • Humans
  • Microbodies (enzymology)
  • Oxidation-Reduction
  • Oxidoreductases (deficiency, metabolism)
  • Phytanic Acid (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: